nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Cyanosis—Etoposide—muscle cancer	0.0321	0.0321	CcSEcCtD
Levorphanol—Respiratory failure—Vincristine—muscle cancer	0.0286	0.0286	CcSEcCtD
Levorphanol—Apnoea—Etoposide—muscle cancer	0.0268	0.0268	CcSEcCtD
Levorphanol—Coma—Vincristine—muscle cancer	0.0257	0.0257	CcSEcCtD
Levorphanol—Lethargy—Dactinomycin—muscle cancer	0.0233	0.0233	CcSEcCtD
Levorphanol—Hypoxia—Methotrexate—muscle cancer	0.0215	0.0215	CcSEcCtD
Levorphanol—Urinary retention—Vincristine—muscle cancer	0.0194	0.0194	CcSEcCtD
Levorphanol—Cardiac arrest—Vincristine—muscle cancer	0.0194	0.0194	CcSEcCtD
Levorphanol—Cyanosis—Methotrexate—muscle cancer	0.0193	0.0193	CcSEcCtD
Levorphanol—Hypokinesia—Doxorubicin—muscle cancer	0.0175	0.0175	CcSEcCtD
Levorphanol—Dysuria—Vincristine—muscle cancer	0.0165	0.0165	CcSEcCtD
Levorphanol—Apnoea—Methotrexate—muscle cancer	0.0161	0.0161	CcSEcCtD
Levorphanol—Cardiac arrest—Etoposide—muscle cancer	0.0157	0.0157	CcSEcCtD
Levorphanol—Sweating—Vincristine—muscle cancer	0.0151	0.0151	CcSEcCtD
Levorphanol—Flushing—Dactinomycin—muscle cancer	0.0147	0.0147	CcSEcCtD
Levorphanol—Respiratory failure—Methotrexate—muscle cancer	0.0139	0.0139	CcSEcCtD
Levorphanol—Thinking abnormal—Doxorubicin—muscle cancer	0.0129	0.0129	CcSEcCtD
Levorphanol—Dyskinesia—Doxorubicin—muscle cancer	0.0126	0.0126	CcSEcCtD
Levorphanol—Renal failure—Etoposide—muscle cancer	0.0125	0.0125	CcSEcCtD
Levorphanol—Coma—Methotrexate—muscle cancer	0.0125	0.0125	CcSEcCtD
Levorphanol—Injection site reaction—Doxorubicin—muscle cancer	0.0117	0.0117	CcSEcCtD
Levorphanol—Abnormal dreams—Doxorubicin—muscle cancer	0.0117	0.0117	CcSEcCtD
Levorphanol—Agitation—Vincristine—muscle cancer	0.0113	0.0113	CcSEcCtD
Levorphanol—Coma—Doxorubicin—muscle cancer	0.0108	0.0108	CcSEcCtD
Levorphanol—Convulsion—Vincristine—muscle cancer	0.0106	0.0106	CcSEcCtD
Levorphanol—Flushing—Etoposide—muscle cancer	0.0106	0.0106	CcSEcCtD
Levorphanol—Abnormal vision—Doxorubicin—muscle cancer	0.0103	0.0103	CcSEcCtD
Levorphanol—Mental disability—Doxorubicin—muscle cancer	0.0102	0.0102	CcSEcCtD
Levorphanol—Lethargy—Methotrexate—muscle cancer	0.0101	0.0101	CcSEcCtD
Levorphanol—Hyperhidrosis—Vincristine—muscle cancer	0.00969	0.00969	CcSEcCtD
Levorphanol—Muscle spasms—Etoposide—muscle cancer	0.00956	0.00956	CcSEcCtD
Levorphanol—Mood swings—Methotrexate—muscle cancer	0.00937	0.00937	CcSEcCtD
Levorphanol—Hypotension—Vincristine—muscle cancer	0.00936	0.00936	CcSEcCtD
Levorphanol—Feeling abnormal—Dactinomycin—muscle cancer	0.00924	0.00924	CcSEcCtD
Levorphanol—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00917	0.00917	CcSEcCtD
Levorphanol—Insomnia—Vincristine—muscle cancer	0.00906	0.00906	CcSEcCtD
Levorphanol—Abdominal pain—Dactinomycin—muscle cancer	0.00887	0.00887	CcSEcCtD
Levorphanol—Lethargy—Doxorubicin—muscle cancer	0.00874	0.00874	CcSEcCtD
Levorphanol—Convulsion—Etoposide—muscle cancer	0.00862	0.00862	CcSEcCtD
Levorphanol—Constipation—Vincristine—muscle cancer	0.00857	0.00857	CcSEcCtD
Levorphanol—Diplopia—Doxorubicin—muscle cancer	0.00857	0.00857	CcSEcCtD
Levorphanol—Affect lability—Doxorubicin—muscle cancer	0.00843	0.00843	CcSEcCtD
Levorphanol—Gastrointestinal pain—Vincristine—muscle cancer	0.00819	0.00819	CcSEcCtD
Levorphanol—Confusional state—Etoposide—muscle cancer	0.00819	0.00819	CcSEcCtD
Levorphanol—Cardiac arrest—Doxorubicin—muscle cancer	0.00815	0.00815	CcSEcCtD
Levorphanol—Mood swings—Doxorubicin—muscle cancer	0.00812	0.00812	CcSEcCtD
Levorphanol—Dysuria—Methotrexate—muscle cancer	0.008	0.008	CcSEcCtD
Levorphanol—Tachycardia—Etoposide—muscle cancer	0.00792	0.00792	CcSEcCtD
Levorphanol—Abdominal pain—Vincristine—muscle cancer	0.00792	0.00792	CcSEcCtD
Levorphanol—Hyperhidrosis—Etoposide—muscle cancer	0.00785	0.00785	CcSEcCtD
Levorphanol—Hypotension—Etoposide—muscle cancer	0.00759	0.00759	CcSEcCtD
Levorphanol—Renal failure—Methotrexate—muscle cancer	0.00749	0.00749	CcSEcCtD
Levorphanol—Sweating—Methotrexate—muscle cancer	0.00731	0.00731	CcSEcCtD
Levorphanol—Vomiting—Dactinomycin—muscle cancer	0.00713	0.00713	CcSEcCtD
Levorphanol—Rash—Dactinomycin—muscle cancer	0.00707	0.00707	CcSEcCtD
Levorphanol—Constipation—Etoposide—muscle cancer	0.00694	0.00694	CcSEcCtD
Levorphanol—Dysuria—Doxorubicin—muscle cancer	0.00692	0.00692	CcSEcCtD
Levorphanol—Feeling abnormal—Etoposide—muscle cancer	0.00669	0.00669	CcSEcCtD
Levorphanol—Nausea—Dactinomycin—muscle cancer	0.00666	0.00666	CcSEcCtD
Levorphanol—Gastrointestinal pain—Etoposide—muscle cancer	0.00664	0.00664	CcSEcCtD
Levorphanol—Dizziness—Vincristine—muscle cancer	0.00663	0.00663	CcSEcCtD
Levorphanol—Visual impairment—Methotrexate—muscle cancer	0.0066	0.0066	CcSEcCtD
Levorphanol—Renal failure—Doxorubicin—muscle cancer	0.00649	0.00649	CcSEcCtD
Levorphanol—Urticaria—Etoposide—muscle cancer	0.00645	0.00645	CcSEcCtD
Levorphanol—Abdominal pain—Etoposide—muscle cancer	0.00642	0.00642	CcSEcCtD
Levorphanol—Vomiting—Vincristine—muscle cancer	0.00637	0.00637	CcSEcCtD
Levorphanol—Sweating—Doxorubicin—muscle cancer	0.00633	0.00633	CcSEcCtD
Levorphanol—Rash—Vincristine—muscle cancer	0.00632	0.00632	CcSEcCtD
Levorphanol—Dermatitis—Vincristine—muscle cancer	0.00631	0.00631	CcSEcCtD
Levorphanol—Bradycardia—Doxorubicin—muscle cancer	0.00603	0.00603	CcSEcCtD
Levorphanol—Nausea—Vincristine—muscle cancer	0.00595	0.00595	CcSEcCtD
Levorphanol—Pruritus—Etoposide—muscle cancer	0.00574	0.00574	CcSEcCtD
Levorphanol—Visual impairment—Doxorubicin—muscle cancer	0.00571	0.00571	CcSEcCtD
Levorphanol—Flushing—Doxorubicin—muscle cancer	0.0055	0.0055	CcSEcCtD
Levorphanol—Dizziness—Etoposide—muscle cancer	0.00537	0.00537	CcSEcCtD
Levorphanol—Arrhythmia—Doxorubicin—muscle cancer	0.00529	0.00529	CcSEcCtD
Levorphanol—Convulsion—Methotrexate—muscle cancer	0.00516	0.00516	CcSEcCtD
Levorphanol—Vomiting—Etoposide—muscle cancer	0.00516	0.00516	CcSEcCtD
Levorphanol—Rash—Etoposide—muscle cancer	0.00512	0.00512	CcSEcCtD
Levorphanol—Dermatitis—Etoposide—muscle cancer	0.00511	0.00511	CcSEcCtD
Levorphanol—Tension—Doxorubicin—muscle cancer	0.00506	0.00506	CcSEcCtD
Levorphanol—Nervousness—Doxorubicin—muscle cancer	0.00501	0.00501	CcSEcCtD
Levorphanol—Muscle spasms—Doxorubicin—muscle cancer	0.00496	0.00496	CcSEcCtD
Levorphanol—Confusional state—Methotrexate—muscle cancer	0.0049	0.0049	CcSEcCtD
Levorphanol—Nausea—Etoposide—muscle cancer	0.00482	0.00482	CcSEcCtD
Levorphanol—Agitation—Doxorubicin—muscle cancer	0.00474	0.00474	CcSEcCtD
Levorphanol—Hyperhidrosis—Methotrexate—muscle cancer	0.0047	0.0047	CcSEcCtD
Levorphanol—Palpitations—Doxorubicin—muscle cancer	0.00456	0.00456	CcSEcCtD
Levorphanol—Hypotension—Methotrexate—muscle cancer	0.00454	0.00454	CcSEcCtD
Levorphanol—Convulsion—Doxorubicin—muscle cancer	0.00447	0.00447	CcSEcCtD
Levorphanol—Insomnia—Methotrexate—muscle cancer	0.0044	0.0044	CcSEcCtD
Levorphanol—Dry mouth—Doxorubicin—muscle cancer	0.0043	0.0043	CcSEcCtD
Levorphanol—Dyspepsia—Methotrexate—muscle cancer	0.00428	0.00428	CcSEcCtD
Levorphanol—Confusional state—Doxorubicin—muscle cancer	0.00425	0.00425	CcSEcCtD
Levorphanol—Shock—Doxorubicin—muscle cancer	0.00414	0.00414	CcSEcCtD
Levorphanol—Tachycardia—Doxorubicin—muscle cancer	0.00411	0.00411	CcSEcCtD
Levorphanol—Hyperhidrosis—Doxorubicin—muscle cancer	0.00407	0.00407	CcSEcCtD
Levorphanol—Feeling abnormal—Methotrexate—muscle cancer	0.00401	0.00401	CcSEcCtD
Levorphanol—Gastrointestinal pain—Methotrexate—muscle cancer	0.00398	0.00398	CcSEcCtD
Levorphanol—Hypotension—Doxorubicin—muscle cancer	0.00393	0.00393	CcSEcCtD
Levorphanol—Urticaria—Methotrexate—muscle cancer	0.00386	0.00386	CcSEcCtD
Levorphanol—Abdominal pain—Methotrexate—muscle cancer	0.00384	0.00384	CcSEcCtD
Levorphanol—Insomnia—Doxorubicin—muscle cancer	0.00381	0.00381	CcSEcCtD
Levorphanol—Dyspepsia—Doxorubicin—muscle cancer	0.00371	0.00371	CcSEcCtD
Levorphanol—Constipation—Doxorubicin—muscle cancer	0.0036	0.0036	CcSEcCtD
Levorphanol—Feeling abnormal—Doxorubicin—muscle cancer	0.00347	0.00347	CcSEcCtD
Levorphanol—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00344	0.00344	CcSEcCtD
Levorphanol—Pruritus—Methotrexate—muscle cancer	0.00344	0.00344	CcSEcCtD
Levorphanol—Urticaria—Doxorubicin—muscle cancer	0.00334	0.00334	CcSEcCtD
Levorphanol—Abdominal pain—Doxorubicin—muscle cancer	0.00333	0.00333	CcSEcCtD
Levorphanol—Dizziness—Methotrexate—muscle cancer	0.00322	0.00322	CcSEcCtD
Levorphanol—Vomiting—Methotrexate—muscle cancer	0.00309	0.00309	CcSEcCtD
Levorphanol—Rash—Methotrexate—muscle cancer	0.00307	0.00307	CcSEcCtD
Levorphanol—Dermatitis—Methotrexate—muscle cancer	0.00306	0.00306	CcSEcCtD
Levorphanol—Pruritus—Doxorubicin—muscle cancer	0.00298	0.00298	CcSEcCtD
Levorphanol—Nausea—Methotrexate—muscle cancer	0.00289	0.00289	CcSEcCtD
Levorphanol—Dizziness—Doxorubicin—muscle cancer	0.00278	0.00278	CcSEcCtD
Levorphanol—Vomiting—Doxorubicin—muscle cancer	0.00268	0.00268	CcSEcCtD
Levorphanol—Rash—Doxorubicin—muscle cancer	0.00265	0.00265	CcSEcCtD
Levorphanol—Dermatitis—Doxorubicin—muscle cancer	0.00265	0.00265	CcSEcCtD
Levorphanol—Nausea—Doxorubicin—muscle cancer	0.0025	0.0025	CcSEcCtD
